Volasertib preclinical activity in high-risk hepatoblastoma.
Kats D, Ricker CA, Berlow NE, Noblet B, Nicolle D, Mevel K, Branchereau S, Judde JG, Stiverson CD, Stiverson CL, Svalina MN, Settelmeyer T, Matlock K, Lathara M, Mussini C, Geller JI, Noakes C, Sloma I, Bharathy N, Cairo S, Keller C.
Kats D, et al. Among authors: sloma i.
Oncotarget. 2019 Nov 5;10(60):6403-6417. doi: 10.18632/oncotarget.27237. eCollection 2019 Nov 5.
Oncotarget. 2019.
PMID: 31741706
Free PMC article.